Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta‐analysis
Journal of Diabetes Investigation · 2026-11 · 17 (11) · 1967-1977
DOI: 10.1111/jdi.70395 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 17.08.2026. Verfasst von Ting Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nephrology, PKUcare CNOOC Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Biomarkers, RNA, Untranslated, RNA, Long Noncoding. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims Diabetic retinopathy (DR), a frequent microvascular complication of diabetes, requires early detection to mitigate progression. Noncoding RNAs (ncRNAs) have emerged as promising diagnostic biomarkers. This meta‐analysis evaluates their overall diagnostic accuracy for DR.
Methods
A comprehensive literature search was conducted across multiple electronic databases, including PubMed, Embase, and Web of Science, to identify relevant studies published until August 2025. Data on study characteristics, quality, and diagnostic performance were pooled. Pooled effect sizes were calculated using a random effects model. Heterogeneity was explored via subgroup analysis and meta‐regression; publication bias was assessed using Deck's funnel plot.
Results
Twenty‐four studies from 17 articles (1,983 patients, 1,437 controls) were included. The pooled analysis demonstrated that ncRNAs achieved a sensitivity of 0.81 and a specificity of 0.84. The area under the curve (AUC) was 0.89, whereas the positive and negative likelihood ratios were 4.96 and 0.23, respectively. LncRNAs demonstrated superior diagnostic performance compared to miRNAs ( P = 0.03). Control type, region, and expression trend did not significantly influence outcomes. Significant heterogeneity was observed ( I 2 > 50%), but sensitivity analysis confirmed robustness, and no notable publication bias was detected.
Conclusion
Circulating ncRNAs, particularly lncRNAs, show high diagnostic potential for DR and represent promising noninvasive biomarkers for early screening and differential diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Nephrology, PKUcare CNOOC Hospital, Tianjin, China.
- Endocrinology Department, Tianjin Fourth Central Hospital, Tianjin, China.
ORCID-Profile: Ting Zhang
Zitieren
APA
Zhang, T., & Xu, D. (2026). Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta‐analysis. Journal of Diabetes Investigation, 17(11), 1967-1977. https://doi.org/10.1111/jdi.70395
Vancouver
Zhang T, Xu D. Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta‐analysis. Journal of Diabetes Investigation. 2026;17(11):1967-1977. doi:10.1111/jdi.70395
BibTeX
@article{Zhang2026,
author = {Zhang, Ting and Xu, Donghong},
title = {Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta‐analysis},
journal = {Journal of Diabetes Investigation},
year = {2026},
volume = {17},
number = {11},
pages = {1967--1977},
doi = {10.1111/jdi.70395}
}
EUVIMED